Zobrazeno 1 - 10
of 86
pro vyhledávání: '"ALEXI VASBINDER"'
Autor:
Alexi Vasbinder, Elizabeth Anderson, Tonimarie Catalan, Anis Ismail, Mousumi Banerjee, Ian Pizzo, Kristen Machado, Pennelope Blakely, Joe‐Elie Salem, Salim S. Hayek
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 6 (2024)
Externí odkaz:
https://doaj.org/article/17dbd8efa83b47a5b99f60a50451057b
Autor:
Bhavna A. Guduguntla, Alexi Vasbinder, Elizabeth Anderson, Tariq U. Azam, Pennelope Blakely, Noah J. Webster, Richard Gonzalez, Toni Atonucci, Judith L. Heidebrink, Bruno Giordani, Laura Zahodne, Benjamin M. Hampstead, Kristine J. Ajrouch, Salim S. Hayek
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 16, Iss 1, Pp n/a-n/a (2024)
Abstract We sought to determine whether the biomarkers of chronic inflammation predict cognitive decline in a prospective observational study. We measured baseline serum soluble urokinase plasminogen activator receptor (suPAR) and high sensitivity C
Externí odkaz:
https://doaj.org/article/30fc7658454b421f906dd1ca7b105d9e
Autor:
Alexi Vasbinder, Tonimarie Catalan, Elizabeth Anderson, Catherine Chu, Megan Kotzin, Danielle Murphy, Halle Cheplowitz, Kristen Machado Diaz, Brayden Bitterman, Ian Pizzo, Yiyuan Huang, Jeffrey Xie, Christopher W. Hoeger, Rayan Kaakati, Hanna P. Berlin, Husam Shadid, Daniel Perry, Michael Pan, Radhika Takiar, Kishan Padalia, Jamie Mills, Chelsea Meloche, Alina Bardwell, Matthew Rochlen, Pennelope Blakely, Monika Leja, Mousumi Banerjee, Mary Riwes, John Magenau, Sarah Anand, Monalisa Ghosh, Attaphol Pawarode, Gregory Yanik, Sunita Nathan, John Maciejewski, Tochukwu Okwuosa, Salim S. Hayek
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 1 (2024)
Background Evidence guiding the pre‐hematopoietic stem cell transplantation (HSCT) cardiovascular evaluation is limited. We sought to derive and validate a pre‐HSCT score for the cardiovascular risk stratification of HSCT candidates. Methods and
Externí odkaz:
https://doaj.org/article/13271a62a2f74e60a59b17357cea8380
Autor:
Sreejata Raychaudhuri, Christina M. Dieli-Conwright, Richard K. Cheng, Ana Barac, Kerryn W. Reding, Alexi Vasbinder, Katherine L. Cook, Vidhya Nair, Pinkal Desai, Michael S. Simon
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
Both obesity and metabolic syndrome are linked to increased incidence of type 2 diabetes, cardiovascular disease (CVD), and cancers of the breast (post-menopausal), and other obesity-related cancers. Over the past 50 years, the worldwide prevalence o
Externí odkaz:
https://doaj.org/article/190a9160c453431fa24f37427cea683d
Autor:
George Hindy, Daniel J. Tyrrell, Alexi Vasbinder, Changli Wei, Feriel Presswalla, Hui Wang, Pennelope Blakely, Ayse Bilge Ozel, Sarah Graham, Grace H. Holton, Joseph Dowsett, Akl C. Fahed, Kingsley-Michael Amadi, Grace K. Erne, Annika Tekmulla, Anis Ismail, Christopher Launius, Nona Sotoodehnia, James S. Pankow, Lise Wegner Thørner, Christian Erikstrup, Ole Birger Pedersen, Karina Banasik, Søren Brunak, Henrik Ullum, Jesper Eugen-Olsen, Sisse Rye Ostrowski, on behalf of the DBDS Consortium, Mary E. Haas, Jonas B. Nielsen, Luca A. Lotta, on behalf of the Regeneron Genetics Center, Gunnar Engström, Olle Melander, Marju Orho-Melander, Lili Zhao, Venkatesh L. Murthy, David J. Pinsky, Cristen J. Willer, Susan R. Heckbert, Jochen Reiser, Daniel R. Goldstein, Karl C. Desch, Salim S. Hayek
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 24 (2022)
People with kidney disease are disproportionately affected by atherosclerosis for unclear reasons. Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived mediator of kidney disease, levels of which are strongly associated with
Externí odkaz:
https://doaj.org/article/97725ccf03d44b8f8179f849f6db2e96
Autor:
Shengyuan Luo, Alexi Vasbinder, Jeanne M. Du‐Fay‐de‐Lavallaz, Joanne Michelle D. Gomez, Tisha Suboc, Elizabeth Anderson, Annika Tekumulla, Husam Shadid, Hanna Berlin, Michael Pan, Tariq U. Azam, Ibrahim Khaleel, Kishan Padalia, Chelsea Meloche, Patrick O'Hayer, Tonimarie Catalan, Pennelope Blakely, Christopher Launius, Kingsley‐Michael Amadi, Rodica Pop‐Busui, Sven H. Loosen, Athanasios Chalkias, Frank Tacke, Evangelos J. Giamarellos‐Bourboulis, Izzet Altintas, Jesper Eugen‐Olsen, Kim A. Williams, Annabelle Santos Volgman, Jochen Reiser, Salim S. Hayek
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 18 (2022)
Background Venous thromboembolism (VTE) contributes significantly to COVID‐19 morbidity and mortality. The urokinase receptor system is involved in the regulation of coagulation. Levels of soluble urokinase plasminogen activator receptor (suPAR) re
Externí odkaz:
https://doaj.org/article/fced70faf2de433098fd1689f287ccf8
Autor:
Grace Pui-Yun Lee, PharmD, BCCCP, Richard K. Cheng, MD, MSc, Alexi Vasbinder, PhD, RN, Sixuan Wu, MSc, Beatrice Wong, PharmD, Stephen D. Farris, MD, Daniel Fishbein, MD, Jenny Man-Ching Wong, PharmD, BCPS
Publikováno v:
Transplantation Direct, Vol 8, Iss 6, p e1329 (2022)
Background. The dosing intensity of antithymocyte globulin as induction therapy in heart transplantation remains controversial. We sought to evaluate the efficacy and safety of rabbit antithymocyte globulin at a total dose of 4.5 mg/kg compared with
Externí odkaz:
https://doaj.org/article/701380f1ca03430fad18c0abc3e6f13e
Autor:
Alexi Vasbinder, Salim S. Hayek
Publikováno v:
American Heart Journal Plus, Vol 17, Iss , Pp 100161- (2022)
Externí odkaz:
https://doaj.org/article/6dece03a2b62445d8cc5296a35e9990a
Autor:
Richard K. Cheng, MD, MSc, Wayne C. Levy, MD, Alexi Vasbinder, RN, Sergio Teruya, MD, Jeffeny De Los Santos, MD, Douglas Leedy, MD, Mathew S. Maurer, MD
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 3, Pp 414-424 (2020)
Background: With increasing diagnoses and available treatment options for transthyretin amyloidosis cardiomyopathy (ATTR-CM), risk stratification of ATTR-CM patients is imperative. Objectives: We hypothesized that diuretic dose and New York Heart Ass
Externí odkaz:
https://doaj.org/article/86d488de6e854dfd82792a3fa4be72b6
Autor:
Michael Pan, Alexi Vasbinder, Elizabeth Anderson, Toniemarie Catalan, Husam R. Shadid, Hanna Berlin, Kishan Padalia, Patrick O’Hayer, Chelsea Meloche, Tariq U. Azam, Ibrahim Khaleel, Erinleigh Michaud, Pennelope Blakely, Abbas Bitar, Yiyuan Huang, Lili Zhao, Rodica Pop‐Busui, Sven H. Loosen, Athanasios Chalkias, Frank Tacke, Evangelos J. Giamarellos‐Bourboulis, Jochen Reiser, Jesper Eugen‐Olsen, Salim S. Hayek
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 24 (2021)
Background Use of angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers (ACEi/ARB) is thought to affect COVID‐19 through modulating levels of angiotensin‐converting enzyme 2, the cell entry receptor for SARS‐CoV2. We soug
Externí odkaz:
https://doaj.org/article/1a21ef7b6f0e4f97ab842163066abf20